Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access
  • Home
  • What We Do
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / Articles / When Did Proteomics Begin?

When Did Proteomics Begin?

Facebook0
Google+0
LinkedIn0
Twitter0

By John Leavitt, Ph.D. Nerac Analyst
Originally Published: July 21, 2014

Over the past two decades I have been somewhat amused by the seemingly abrupt emergence of the fields called “genomics” and “proteomics” and all of the other “…omics”. The fanfare surrounding their emergence seems similar in effect to drinking too much espresso in the morning.

The earliest review on the subject of “proteomics” (with an “s”) that I could find was published in 1997 by James entitled “Protein identification in the post-genome era: the rapid rise of proteomics” in the Quarterly Review of Biophysics, a year when only a few papers mentioned this word. The word “proteome” was actually first trademarked by Jim Garrels at Proteome, Inc. in 1995. Simply put, “proteomics” now defines an industry that is focused on linking specific proteins to disease states for the purpose of improved diagnosis and treatment.

Want to read the rest of the article? Fill out the form to download: When Did Proteomics Begin?
Get Download Link

 

 

 

 

Related Posts

  • Nerac Announces Addition to Analyst Team
    36
    New analyst brings extensive experience in engineering, energy and environmental systems Read the full release here.
    Tags: analyst, read, full, published, nerac
  • Nerac Announces Addition to Analyst Team
    30
    New analyst brings extensive experience in the biotechnology industry, primarily in the areas of chemical and biochemical defense systems, electrochemical devices, nanotechnology, materials chemistry and physical-organic chemistry Read the full release here.
    Tags: read, analyst, full, industry, published, nerac
  • Nerac to Host the next XcellR8 Meeting May 25th
    30
    XcellR8 welcomes welcomes Roger LaFlamme, Co-founder and COO of Rapid Radiant Technologies Read the full release here.
    Tags: read, rapid, full, published, nerac
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies emerging markets energy EU MDR FDA food Industry 4.0 innovation Inspiring Next intellectual property intellectual property strategies IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation Order 650 patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting XcellR8
  • Facebook
  • Google+
  • Linkedin
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities

Copyright © 2021 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!
  • This field is for validation purposes and should be left unchanged.